Home › Therapeutic areas › Hematology › AL Amyloidosis
AL Amyloidosis (4 companies)
Companies with an active program in AL Amyloidosis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AUTL | Autolus Therapeutics | HematologyImmunology+3 Rare | 1 | Approved | $341M | 12 |
| FBIO | Fortress Biotech | DermatologyHematology+3 Rare | 1 | Approved | $61.7M | 12 |
| IMMX | Immix Biopharma | Hematology Rare | 1 | Phase 1 | $577M | 1 |
| IONS | Ionis Pharmaceuticals | CardiovascularHematology+5 Rare | 2 | Approved | $6.55B | 29 |
No companies match.